AzTrials
AzTrials

Autistic DisorderNCT01882153

Evaluating Parent Delivered Interventions for Children With Autism

A study testing Pivotal Response Training (PRT), PACE Therapy and PACE and PRT Hybrid in people with Autistic Disorder and Developmental Disabilities, run by Stanford University at 1 site in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The investigators will assess the efficacy of parent delivered interventions in the treatment of social and communication deficits in children with autism. By collecting information about parent and child functioning before and after intervention, the investigators will be able to determine whether the intervention is… Read more about this study

Who is it for?
Ages 18 months to 17 years
Conditions the study is for
Autistic Disorder, Developmental Disabilities
What is being tested?
Pivotal Response Training (PRT), PACE Therapy and PACE and PRT Hybrid
Could I receive a placebo?
No, everyone receives an active treatment
How many people
104 participants
Where
1 siteUnited States
Study dates
Feb 2010to 18 Feb 2022
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 months to 17 years
  • All sexes
  • No healthy volunteers
  • Child

Who may be able to join

  • Children between the ages of 1.6 and 17.11 years of age
  • Males and females
  • Diagnosis of autism based on DSM-IV-TR criteria, an expert clinical evaluation, and ADOS or ADI-R if needed
  • Receiving or will receive a parent delivered intervention to alleviate symptoms related to their diagnosis of autistic disorder
  • Have a care provider that will reliably bring subjects to their chosen intervention and clinic visits, and is trustworthy to provide accurate accounts of services provided to the subject
  • Inclusion Criteria for developmentally delayed participants:
Show all 12Show fewer
  • Will have an age range between 1.6 and 17.11 years of age
  • Males or females
  • Diagnosis of a developmental delay or disorder based on DSM-IV-TR, ICD-10, and an expert clinical evaluation
  • Have historical evidence of significant abnormal developmental milestones as determined by neurological history
  • Receiving or will receive a parent delivered intervention
  • Have a care provider that will reliably bring subjects to their chosen intervention and clinic visits, and is trustworthy to provide accurate accounts of services provided to the subject

Who cannot join

  • Is medically unstable (e.g., more than one seizure a month)
  • Have a medical diagnosis that causes autism like symptomology (e.g., Fragile X, Down syndrome, Angelman's syndrome, tuberous sclerosis, Rett's disorder)
  • Is medically unstable (e.g., more than one seizure a month)
  • Has a diagnosis of ASD

Trial locations and contacts

1 site in 1 country.

United States1 site
  • Stanford University School of Medicine

    Stanford, California, 94305

Other trials in United States

About this study

The investigators will assess the efficacy of parent delivered interventions in the treatment of social and communication deficits in children with autism. By collecting information about parent and child functioning before and after intervention, the investigators will be able to determine whether the intervention is effective in improving child social communication and reducing parent stress.

Being tested
Pivotal Response Training (PRT), PACE Therapy, PACE and PRT Hybrid
Medical subject headings
Autistic Disorder, Developmental Disabilities

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Pivotal Response Training (PRT)Behavioural

    The behaviorally-based intervention is a treatment model that uses the principles of Applied Behavior Analysis (Koegel, Openden, Fredeen, \& Koegel, 2006) to increase children's adaptive behaviors and decrease maladaptive behaviors.

  • PACE TherapyBehavioural

    The developmentally based intervention is grounded in a development theory, that focuses on child-directed interactions with warm and caring individuals that aid in acquiring missed developmental and functional milestones.

  • PACE and PRT HybridBehavioural

    The hybrid based treatment has an eclectic approach that incorporates both systematic (behaviorally-based) and affect-based learning (developmentally-based)that focuses on increasing children's skill development (http://www.pacificautism.org).

Study groups in NCT01882153
Study groupRoleWhat they receive
Developmentally Based InterventionExperimentalNot described
Receives: Behavioral: PACE Therapy; Behavioral: PACE and PRT Hybrid
Behaviorally Based InterventionExperimentalNot described
Receives: Behavioral: Pivotal Response Training (PRT); Behavioral: PACE and PRT Hybrid

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change in CGI-S (Clinical Global Impression - Severity)

    Measured: Difference from Baseline to Week 12

  2. Change in SRS (Social Responsiveness Scale)

    Measured: Difference from Baseline to Week 12

  3. Change in CDI (Communicative Development Survey) Score

    Measured: Difference from Baseline to Week 12

  4. Change in social and communication behaviors as assessed by standardized laboratory observations

    Measured: Difference from Baseline to Week 12

Secondary outcomes (6)
  1. Change in VABS (Vineland Adaptive Behavior Scale) Score

    Measured: Difference from Baseline to Week 12

  2. Change in social and communication behaviors as assessed from home videos

    Measured: Difference from Baseline to Week 12

  3. Change in PSI (Parenting Stress Index) Score

    Measured: Difference from Baseline to Week 12

  4. Change in FES (Family Empowerment Scale) Score

    Measured: Difference from Baseline to Week 12

  5. Change in frequency and duration of investigation therapy

    Measured: Difference from Baseline to Week 12

  6. Change in demographics data

    Measured: Difference from Baseline to Week 12

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted20 Jun 2013 (estimated)
  2. Study startFeb 2010
  3. Primary completion18 Feb 2022
  4. Study completion18 Feb 2022

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Non-randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
104 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT01882153
Sponsor's protocol ID
SU-11232011-8727
Status last verified
Jul 2023
First submitted
17 Jun 2013
Last updated
14 Jul 2023
Results posted
No

Questions about this trial

What is this clinical trial studying?

A study testing Pivotal Response Training (PRT), PACE Therapy and PACE and PRT Hybrid in people with Autistic Disorder and Developmental Disabilities, run by Stanford University at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 12 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 14 Jul 2023. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change in CGI-S (Clinical Global Impression - Severity) (time frame: Difference from Baseline to Week 12). The study lists 4 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 14 Jul 2023; AzTrials last refreshed its copy on 1 Nov 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in